The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 159 participants.

Also called NCT06321575

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 159 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06321575
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06321575. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06-20 (actual); primary completion 2026-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Acronym
GREAT
Condition
Peripheral Arterial Disease
Intervention (Device)
Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)
Lead sponsor
Nipro Vascular Innovations Americas, Inc (class: industry)
Collaborator
Bright Research, Inc. (class: not stated)
Collaborator
Yale Cardiovascular Research Group (class: other)

Record details

Record id
cardio:ct-nct06321575
Content hash
7e7c081b432e2d44bc8d3c095b749c9c3f1b3eb1df7d44d3f2ff7b42fbe23b89